Literature DB >> 20447794

In situ formation of nanoparticles upon dispersion of melt extrudate formulations in aqueous medium assessed by asymmetrical flow field-flow fractionation.

Johanna Kanzer1, Stefan Hupfeld, Terje Vasskog, Ingunn Tho, Peter Hölig, Markus Mägerlein, Gert Fricker, Martin Brandl.   

Abstract

In recent years melt extrudates (e.g. Meltrex) have proven to be a promising formulation tool for poorly water-soluble and poorly bioavailable drugs. During the hot-melt extrusion process solid dispersions are formed. For several of these formulations improved bioavailabilities have been reported; the mechanism behind, however is still not very well understood. The aim of this study was to investigate whether solid dispersions prepared by melt extrusion upon dispersion in aqueous medium form particles and/or supramolecular assemblies. The formulation investigated here contained the human immunodeficiency virus (HIV) protease inhibitors lopinavir and ritonavir, polyvinylpyrrolidone-vinyl acetate copolymer (Kollidon VA64), sorbitan monolaurate (Span((R)) 20) and hydrophilic fumed silica (Aerosil 200). The aqueous dispersions originating from both, API-containing and placebo formulation were investigated using photon correlation spectroscopy (PCS) and asymmetrical flow field-flow fractionation (AsFlFFF) with subsequent online multi-angle light-scattering (MALS) particle size analysis. The content of both APIs in the AsFlFFF-fractions was quantified using high performance liquid chromatography-mass spectrometry. PCS indicated sub-micron particles. AsFlFFF revealed the co-existence of up to three different types of colloidal to nanoparticulate assemblies in the aqueous dispersions. Even though a complete resolution of the composition of the sub-fractions could not be achieved, the following types could be clearly distinguished: The first fraction eluting from AsFlFFF, appears to be colloidal polymer. Only marginal amounts of the APIs were found associated with the polymer. Secondly, API-rich nanoparticles eluted. Thirdly, nanoparticulate assemblies assigned to sorbitan monolaurate and/or hydrophilic fumed silica were identified. A limited amount of drug was found associated with this fraction. Using AsFlFFF-MALS the size of particles in fractions could be determined. From this experience AsFlFFF is regarded as promising technique for investigation of particles/structures originating during dispersion of melt extrudates in aqueous medium in terms of size and type of nanoparticles and their API-content. Copyright (c) 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20447794     DOI: 10.1016/j.jpba.2010.04.012

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  6 in total

Review 1.  Challenges and Strategies in Thermal Processing of Amorphous Solid Dispersions: A Review.

Authors:  Justin S LaFountaine; James W McGinity; Robert O Williams
Journal:  AAPS PharmSciTech       Date:  2015-08-26       Impact factor: 3.246

2.  Using Environment-Sensitive Fluorescent Probes to Characterize Liquid-Liquid Phase Separation in Supersaturated Solutions of Poorly Water Soluble Compounds.

Authors:  Shweta A Raina; David E Alonzo; Geoff G Z Zhang; Yi Gao; Lynne S Taylor
Journal:  Pharm Res       Date:  2015-06-27       Impact factor: 4.200

3.  Impact of Solubilizing Additives on Supersaturation and Membrane Transport of Drugs.

Authors:  Shweta A Raina; Geoff G Z Zhang; David E Alonzo; Jianwei Wu; Donghua Zhu; Nathaniel D Catron; Yi Gao; Lynne S Taylor
Journal:  Pharm Res       Date:  2015-05-28       Impact factor: 4.200

Review 4.  Supersaturation-Based Drug Delivery Systems: Strategy for Bioavailability Enhancement of Poorly Water-Soluble Drugs.

Authors:  Arvind Sharma; Kanika Arora; Harapriya Mohapatra; Rakesh K Sindhu; Madalin Bulzan; Simona Cavalu; Gulsheen Paneshar; Hosam O Elansary; Ahmed M El-Sabrout; Eman A Mahmoud; Abdullah Alaklabi
Journal:  Molecules       Date:  2022-05-06       Impact factor: 4.927

5.  The amorphous solid dispersion of the poorly soluble ABT-102 forms nano/microparticulate structures in aqueous medium: impact on solubility.

Authors:  Kerstin J Frank; Ulrich Westedt; Karin M Rosenblatt; Peter Hölig; Jörg Rosenberg; Markus Mägerlein; Gert Fricker; Martin Brandl
Journal:  Int J Nanomedicine       Date:  2012-11-12

Review 6.  Mechanisms of increased bioavailability through amorphous solid dispersions: a review.

Authors:  Andreas Schittny; Jörg Huwyler; Maxim Puchkov
Journal:  Drug Deliv       Date:  2020-12       Impact factor: 6.419

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.